CAPRICOR THERAPEUTICS, INC. (CAPR) Insider Trading -- Recent Executive & Director Transactions

7 insiders reported 14 Form 4 transactions for CAPRICOR THERAPEUTICS, INC. (CAPR) over the past 18 months (most recent 2026-05-19). Recent activity: Bergmann Anthony (CHIEF FINANCIAL OFFICER) Buy 3,000 shares, Litvack Frank (Director) Buy 3,937 shares, Sabar Karimah Es (Director) Buy 7,529 shares, Sabar Karimah Es (Director) Sell 7,529 shares, Krasney Karen (EVP, GENERAL COUNSEL) Buy 2,500 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-19Bergmann AnthonyCHIEF FINANCIAL OFFICERBuy3,000$4,170
2026-05-14Litvack FrankDirectorBuy3,937$5,472
2026-04-03Sabar Karimah EsDirectorBuy7,529$23,942
2026-04-03Sabar Karimah EsDirectorSell7,529$240,928
2026-03-27Krasney KarenEVP, GENERAL COUNSELBuy2,500$3,475
2025-12-23DUNBAR GEORGE W JRDirectorBuy3,000$4,170
2025-03-05Marban LindaCHIEF EXECUTIVE OFFICERBuy25,000$34,750
2025-03-05Marban LindaCHIEF EXECUTIVE OFFICERSell12,500$0
2025-03-04DUNBAR GEORGE W JRDirectorBuy750$1,042
2025-03-04Litvack FrankDirectorBuy25,000$34,750
2025-03-04Litvack FrankDirectorSell2,543$34,763
2025-03-04Bergmann AnthonyCHIEF FINANCIAL OFFICERBuy2,500$3,475
2025-02-28COLLIER EARL M JRDirectorBuy750$1,042
2025-01-06Bergmann AnthonyCHIEF FINANCIAL OFFICERBuy3,342$0

Source: SEC Form 4 filings · as of 2026-05-19